EMA Releases Guideline on Covariates in Clinical Trials

Drugmakers planning to assign clinical trial participants to a separate arm of the study based on baseline monitoring must report those plans to the European Medicines Agency, including which factors — called covariates — they plan to rely on to make those assignments.

Often, these covariates are measures taken early in a trial, such as a baseline measurement, that would prompt sponsors to stratify patients into different treatment arms, according to guidance released last week.


RSS Clinical Trials Advisor

RSS Good Manufacturing Practices – GMP Newsletter von

  • LOGFILE No. 35/2017 – Technology Transfer Phases September 19, 2017
    Technology Transfer Phases An excerpt from GMP Series A Successful Concept for Technology Transfer in Drug Manufacturing 5 minutes reading time by Christian Gausepohl, PhDmehr
  • FDA seeks input on “Continuous Manufacturing” September 18, 2017
    On September 11, 2017, Michael Kopcha, Ph.D., R.Ph. and FDA’s director of the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research (CDER), announced the opening of a public docket to seek input from experts in areas of science, technology and best practices concerning “Continuous Manufacturing”. To establish common guiding principles to this new […]
  • Short news: PIC/S / Swissmedic September 18, 2017
    PIC/S: Three New Participating AuthoritiesSwissmedic: Combat Against Illegal Pharmaceuticalsmehr